Alliancebernstein L.P. Adc Therapeutics Sa Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Alliancebernstein L.P. holds 22,020 shares of ADCT stock, worth $44,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,020

Previous 22,020 -0.0%

Holding current value

$44,040

Previous $69,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.55 - $5.09 $56,150 - $112,081	22,020 New	22,020 $69,000
Q4 2022 Feb 14, 2023	SELL	$2.87 - $5.24 $258,885 - $472,668	-90,204 Reduced 3.09%	2,824,956 $10.8 Million
Q3 2022 Nov 15, 2022	SELL	$4.66 - $10.31 $216,522 - $479,043	-46,464 Reduced 1.57%	2,915,160 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$5.96 - $14.99 $27,225 - $68,474	4,568 Added 0.15%	2,961,624 $23.5 Million
Q1 2022 May 13, 2022	BUY	$13.28 - $20.03 $1.98 Million - $2.99 Million	149,333 Added 5.32%	2,957,056 $43.4 Million
Q4 2021 Feb 14, 2022	BUY	$19.29 - $31.51 $2.96 Million - $4.84 Million	153,506 Added 5.78%	2,807,723 $56.7 Million
Q3 2021 Nov 10, 2021	SELL	$20.45 - $30.0 $8.16 Million - $12 Million	-399,031 Reduced 13.07%	2,654,217 $72.1 Million
Q2 2021 Jul 30, 2021	BUY	$20.38 - $27.04 $8.62 Million - $11.4 Million	422,757 Added 16.07%	3,053,248 $74.3 Million
Q1 2021 May 06, 2021	BUY	$22.75 - $34.05 $18.9 Million - $28.3 Million	829,755 Added 46.08%	2,630,491 $64.2 Million
Q4 2020 Feb 08, 2021	BUY	$25.26 - $38.02 $12.7 Million - $19.1 Million	502,171 Added 38.67%	1,800,736 $57.6 Million
Q3 2020 Nov 12, 2020	BUY	$32.87 - $51.05 $12.2 Million - $18.9 Million	370,988 Added 40.0%	1,298,565 $42.8 Million
Q2 2020 Aug 13, 2020	BUY	$29.65 - $46.81 $27.5 Million - $43.4 Million	927,577 New	927,577 $43.4 Million

Others Institutions Holding ADCT

# of Institutions

Shares Held

55.1M

Call Options Held

82.7K

Put Options Held

31.5K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $155M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Adc Therapeutics Sa Transaction History